Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO GeneCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, congenital stationary night blindness autosomal dominant 1, contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A, eye disorder, hereditary disease, inherited retinal dystrophy, nervous system disorder, retinal degeneration, retinal disorder, retinitis, retinitis pigmentosa, vision disorderActive, not recruitingPhase 1 / Phase 22022-05-06NCT04123626

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
ProQR Therapeutics2

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Casey Eye Institute, OHSUPortlandUnited States2
Retina Foundation of the SouthwestDallasUnited States38
Shriners UK Ophthalmology - University of KentuckyLexingtonUnited States1
Sue Anschutz-Rogers Eye Center, University of Colorado - Dept. of OphthalmologyAuroraUnited States1
VitreoRetinal AssociatesGainesvilleUnited States1